Author Archive | Yali Friedman

Tracking 20 Years of Compound-to-Target Output from Literature and Patents

This article was originally published at https://www.drugpatentwatch.com/blog/tracking-20-years-compound-target-output-literature-patents/ This article was originally published by Christopher Southan, Peter Varkonyi, Kiran Boppana, Sarma A.R.P. Jagarlapudi, and Sorel Muresan at PLoS ONE 8(10): e77142. Abstract The statistics of drug development output and… The post Tracking 20 Years of Compound-to-Target Output from Literature and Patents appeared first on DrugPatentWatch. The post […]

Continue Reading

Can Artificial Intelligence Help Drug Development?

By Larry Ramer, DrugPatentWatch writer Artificial intelligence, or AI, has advanced significantly in recent years and could significantly lower pharma companies’ R&D costs by enabling precision medicine and greatly reducing… The post Can Artificial Intelligence Help Drug Development? appeared first on DrugPatentWatch. The post Can Artificial Intelligence Help Drug Development? appeared first on Biotechblog.

Continue Reading

Accelerating Drug Approvals in the US

This article was originally published at https://www.drugpatentwatch.com/blog/accelerating-drug-approvals-us/ By: Pankaj Mondal, DrugPatentWatch Staff Writer When it comes to measuring the success of a new drug, the amount of time required to complete the entire approval process become a… The post Accelerating Drug Approvals in the US appeared first on DrugPatentWatch. The post Accelerating Drug Approvals in […]

Continue Reading

The Importance of Pharmaceutical Competitor Analysis

The US pharmaceutical industry is heavily competitive, with nine out of the top ten pharmaceutical companies based in the US. In recent years though, the market has become even more competitive… The post The Importance of Pharmaceutical Competitor Analysis appeared first on DrugPatentWatch. The post The Importance of Pharmaceutical Competitor Analysis appeared first on Biotechblog.

Continue Reading

New tentative approval for Watson Labs drug dienogest; estradiol valerate

Dienogest; estradiol valerate is the generic ingredient in one branded drug marketed by Bayer Hlthcare and is included in one NDA. There are four patents protecting this compound. This ingredient… The post New tentative approval for Watson Labs drug dienogest; estradiol valerate appeared first on DrugPatentWatch. The post New tentative approval for Watson Labs drug […]

Continue Reading

New patent for Indivior Inc drug SUBOXONE

Annual Drug Patent Expirations for SUBOXONE Suboxone is a drug marketed by Indivior Inc and is included in two NDAs. It is available from five suppliers. There are four patents… The post New patent for Indivior Inc drug SUBOXONE appeared first on DrugPatentWatch. The post New patent for Indivior Inc drug SUBOXONE appeared first on […]

Continue Reading

Which pharmaceutical companies have the most suppository dosed drugs?

This chart shows the pharmaceutical companies with the most suppository dosed drugs. For a different perspective, see the most popular dosage types. The companies with the most suppository dosed drugs… The post Which pharmaceutical companies have the most suppository dosed drugs? appeared first on DrugPatentWatch. The post Which pharmaceutical companies have the most suppository dosed […]

Continue Reading

New tentative approval for Watson Labs drug dienogest; estradiol valerate

Dienogest; estradiol valerate is the generic ingredient in one branded drug marketed by Bayer Hlthcare and is included in one NDA. There are four patents protecting this compound. This ingredient… The post New tentative approval for Watson Labs drug dienogest; estradiol valerate appeared first on DrugPatentWatch. The post New tentative approval for Watson Labs drug […]

Continue Reading

Which pharma companies have the most supplementary protection certificates?

This chart shows the drug companies with the most supplementary protection certificates (SPCs). SPCs are used in European Union and select others to encourage pharmaceutical innovation by compensating for the… The post Which pharma companies have the most supplementary protection certificates? appeared first on DrugPatentWatch. The post Which pharma companies have the most supplementary protection […]

Continue Reading

New tentative approval for Watson Labs drug dienogest; estradiol valerate

Dienogest; estradiol valerate is the generic ingredient in one branded drug marketed by Bayer Hlthcare and is included in one NDA. There are four patents protecting this compound. This ingredient… The post New tentative approval for Watson Labs drug dienogest; estradiol valerate appeared first on DrugPatentWatch. The post New tentative approval for Watson Labs drug […]

Continue Reading